Umugore wo muri Nouvelle-Zélande/ New Zealand yishwe n’urukingo rwa Pfizer

Igihugu cya Nouvelle-Zélande/ New Zealand cyatangaje umuntu wa mbere cyemeza ko yapfuye biturutse ku rukingo rwa Covid-19 yatewe.

Itsinda ryigenga ry’abahanga bakurikiranira hafi ibijyanye n’umutekano w’inkingo riviga ko urupfu rw’uyu mugore “rushobora” kuba rwavuye ku ndwara ya myocardite/myocarditis, indwara y’ubushe bw’umutsi w’umutima.

Iri tsinda nkuko BBC dukesha iyi nkuru ibitangaza rivuga kandi ko hari ibindi bibazo by’ubuzima bishobora kuba “byatumye uru rukingo rugira ingaruka mbi”.

Abagenzuzi b’I Bulayi bavuga ko myocardite/myocarditis ari ingaruka “zidakunze kugaragara” kandi ko inyungu z’uru rukingo zisumba cyane ingaruka mbi zishobora kubaho.

Hagati aho, impamvu nyamukuru y’uru rupfu ntiramenyekana. Ariko, itsinda ukurikiranira hafi ibijyanye n’inkingo za Covid (Covid-19 Vaccine Independent Safety Monitoring Board) rivuga ko myocardite/myocarditis “ishobora kuba yatewe n’uru rukingo”.

Mu itangazo iri tsinda ryasohoye, rivuga ko ari rwo rupfu rwa mbere muri Nouvelle-Zélande rufitanye isano n’urukingo Pfizer rwa Covid-19.

Iri tangazo rikomeza riti: “N’aho ikigo gishinzwe gukurikiranira hafi ingaruka mbi z’inkingo (Centre for Adverse Reactions Monitoring) kimaze kubona andi makuru y’umuntu wapfuye hahise imisi akingiwe, nta na hamwe izi mpfu zifitanye isano n’urukingo”.

Urupfu rw’uyu mugore rurimo gukorwaho amaperereza yimbitse, ushinzwe kuyakora akaba yiteguye gutanga icyegeranyo. Abategetsi nta yandi makuru baratanga, harimo n’imyaka y’uyu mugore.

Ikigo gishinzwe imiti cy’u Bulayi (European Medicines Agency, EMA) kivuga ko ingaruka za myocardite/myocarditis ziturutse ku nkingo za Covid za Pfizer na Moderna, “zidakunze kuboneka”, kikongera ho ko zikunze kugaragara cyane cyane ku bagabo bakiri bato.

Nk’urugero, Ubwongereza buvuga ko bwabonye abantu 195 bahuye n’icyo kibazo cya myocardite/myocarditis mu bantu batewe urukingo rwa Pfizer, iyi mibare ikaba iri ku rugero rwa 5/1.000.000.

Munyaneza Theogene / intyoza.com

Leave a Reply

Your email address will not be published. Required fields are marked *